An educational model of glucose homeostasis in diabetes mellitus by Dió, Mihály et al.
29New Medicine 
1/2014
© Borgis
regional studies on health science
o r i g i n a l  p a p e r s
AN EDUCATIONAL MODEL OF GLUCOSE  
HOMEOSTASIS IN DIABETES MELLITUS
*Mihály Dió1, Tibor Deutsch1, Judit Mészáros2
1Department of Medical Imaging and Technology, Faculty of Health Sciences, Semmelweis University,  
 Budapest, Hungary  
 Head of Department: Éva Kis, PhD 
2Faculty of Health Sciences, Semmelweis University, Budapest, Hungary 
 Head of the Faculty: prof. Zoltán Zsolt Nagy, PhD
Summary
A simulation model of glucose homeostasis in diabetes mellitus could be very useful for patient, student and health-carer train-
ing. In this paper, the first design phase of the modelling work is presented. The new comprehensive educational model of 
glucose homeostasis described in this report attempts to provide an anatomically explicit basis for simulations that incorporates 
up-to-date quantitative knowledge about glucose metabolism and its control by insulin. The overall glucose homeostasis model 
consists of differential mass balance equations complemented by differential or algebraic relationships for each metabolic 
source or sink term. Major clinical parameters such as basal glucose and insulin levels along with hepatic glucose production are 
used for customizing the model for individual patients. The educational model allows the simulation of 24-hour blood glucose 
(BG) profiles for non-diabetic subjects as well as for people with insulin-dependent (type 1) diabetes mellitus (IDDM) and non-
insulin dependent (type 2) diabetes mellitus (NIDDM). Graphs of the model functions are provided, and example simulations 
are shown demonstrating the inner workings of the model. 
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INTRODUCTION
Diabetes mellitus is a syndrome of impaired carbohy-
drate, fat, and protein metabolism caused by either a lack 
of insulin secretion or decreased sensitivity of the tissue 
to insulin. For people with insulin-dependent (type 1) dia-
betes mellitus (IDDM), insulin must be provided from an 
exogenous source other than the pancreas. People with 
NIDDM may also end up requiring insulin.
Insulin requiring patients should adjust their insulin 
dose(s) according to their blood sugars and in relation 
to various lifestyle events. This represents a daily chal-
lenge, as many factors influence glycaemia, such as diet, 
meal composition, and exercise, as well as stress. Often 
diabetic patients have developed their skills by some trial-
and-error-like training over a long period of time. The task 
is non-trivial, and many patients would benefit from some 
sort of educational support. Learning how to modulate 
insulin therapy in relation to food intake and insulin in-
jections to prevent out-of-target BG deviations would be 
very useful. However, education of people with diabetes 
requires a level of clinical expertise which although pres-
ent in specialised diabetes units, and some general prac-
tices with an interest in diabetes, is not always to be found 
in other sectors of the health service. 
The working hypothesis underlying the interactive ed-
ucational diabetes simulation approach has been that en-
abling people to try out different therapeutic and dietary 
alternatives can help them to gain experience in achiev-
ing glycaemic control, without the risks of actually experi-
encing hypoglycaemic or hyperglycaemic episodes. With 
the simulator, users can specify nearly unlimited numbers 
of ‘virtual diabetic patients’ and test how different types of 
treatment, doses and dosing regimens, and even lifestyle 
(dietary) changes affect the daily BG profile. If a simu-
lated regimen is found unable to keep glycaemia within 
desired limits, users can try alternative management regi-
mens that seem to improve this daily pattern. 
The circulating concentrations of glucose are nor-
mally maintained in health within a narrow range by 
homeostatic control mechanisms involving endocrine 
hormones, principally insulin and glucagon. Glucose 
metabolism involves a wide spectrum of transport and 
metabolic processes some of which are difficult to mea-
sure in vivo. Mathematical models, therefore, have the 
potential to play an important role in the identification 
and quantification of mechanisms.
Clinically relevant models describing the important me-
tabolite and hormone dynamics in diabetic patients have 
been developed since the 1960s; for recent reviews see 
Makroglou (1) and Stahl et al. Model formulations vary in 
form and detail as primarily determined by their intended 
use. While the glucoregulatory system involves multiple 
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by Trajanowski et al. (16). The model was also extended 
to support monomeric insulin analogues (17-18). 
The accumulated new knowledge and recent models 
have allowed the development of a comprehensive edu-
cational model of glucose homeostasis which is able to 
represent conditions typical for both IDDM and NIDDM 
patients. This article overviews the new model and pro-
vides a description of some of the model’s output.
METHODS
Our goal has been to produce an educationally useful 
model of glucose homeostasis for teaching, self-learning, 
and demonstration purposes. The model of Sorensen (7) 
were taken as a starting point for the current work, but rea-
sonable simplifications of the original model have been 
made. The new model presented here comprises two 
major sub-models describing glucose and insulin kinetics. 
These two sub-models are linked by control functions de-
scribed as algebraic expressions. Figure 1 shows the flow 
diagram displaying the elements that appear to be essen-
tial for a dynamic educational model. The arrows show the 
blood flow direction and the rectangular blocks represent 
different compartments. Continuous lines denote fluxes of 
material and dashed lines denote control signals.
The left hand side of the figure shows the diagram 
of glucose kinetics which contains the tissues where a 
large portion of metabolism operates using most of the 
glucose for energy. These sites include blood, liver, and 
peripheral compartments. The blood compartment is 
created by pooling heart, lung, brain, gut and kidney tis-
sues but excludes liver and peripheral tissues. Muscles 
and adipose tissue are represented as the periphery. Be-
cause of a significant gradient from capillaries to the in-
tracellular space, two sub-compartments are considered 
metabolites and hormones, most existing models focus 
only on the dynamics of glucose and insulin (2-6). Various 
approaches have been used including ordinary differential 
equations, delayed differential equations, partial differential 
equations, and integro-differential equations (1).
Physiologically based models, with the body compart-
mentalized into physiological compartments representing 
the organs and tissues important in terms of glucose ho-
meostasis. (7-9). The Sorensen (7) physiological model 
comprised a system of 22 mass balance equations, which 
predict glucose, insulin, and glucagon concentrations in 
each compartment. Puckett (8) developed a model very 
similar to Sorensen’s, but did not include glucagon’s ef-
fects, and removed all transport terms besides the meta-
bolic sources and sinks. Farmer et al. developed a model 
framework to describe the biochemical species associ-
ated with glucose metabolism (9). Recently the Sorensen 
model was adapted for NIDDM patients (10). Different 
models have also been proposed to describe the dynam-
ics of glucose absorption after meals and the absorption 
of insulin following sc injections of different insulin prepa-
rations. Mari et al. (11) proposed another model to de-
scribe insulin secretion involving the time delay between 
the glucose signal and insulin secretion. 
Subcutaneous insulin absorption is a complex pro-
cess which is affected by many factors including tissue 
blood flow, injection site/depth, injected volume and 
concentration (12). Insulin absorption from subcutane-
ous injection or infusion has been widely studied since 
Binder et al. (12). For a review see Nucci & Cobelli (13). 
Berger & Rodbard (14) prediction of plasma insulin levels 
for various insulin preparations. More on physiology and 
pharmacokinetics, has been described by Mosekilde 
and colleagues (15). This approach was later modified 
Fig. 1. The scheme of the model.
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has been done to incorporate this model into the AIDA 
v4 diabetes simulator.
The model described in this report contains a large 
number of parameters. Model parameters were selected 
to have clear anatomical and/or physiological mean-
ing. Patient populations 23-24 individual patients can be 
generated by setting model parameters to reflect the or-
gan affected and the extent of derangement. These de-
rangements separately or combined can be modelled 
systematically as the source and sink terms in the differ-
ent organs. Using parameters such as hepatic glucose 
effectiveness (glucose control on endogenous glucose 
production suppression) and hepatic insulin sensitivity 
(insulin control on endogenous glucose production sup-
pression) enables a more detailed specification to be 
made of diabetic patients with special impairments. 
The model is integrated using a fourth-order Runge-
Kutta method with a step size of 0.25 minute. The model 
is computed using the Berkeley Madonna simulation tool 
(www.berkeleymadonna.com). The underlying model of 
glucose-insulin interaction will be desribed elsewhere. 
RESULTS
The model is implemented with a view to providing 
rapid real-time simulation of BG profiles over a 24-hour 
period for individuals with IDDM and NIDDM with different 
types and degrees of derangements in their metabolism. 
In the figure 2 the upper graph shows the simulated 
BG levels while the lower graphs serves to display the 
timing and doses of insulin injections and meals. Super-
imposed on this graph is the predicted plasma insulin 
profile as calculated by the software. 
It shows a simulation after a change in the “virtual 
patient’s” regimen, with the addition of 5 units of a short-
acting (Actrapid) insulin injection at 6:00am. The resul-
tant lowering of the BG profile is clear to see. 
Figure 2 shows a 70 kg male, IDDM patient on a three 
times daily insulin injection regimen. It shows the rate 
of appearance of glucose in plasma following meals of 
the same size with different compositions simulated with 
the proposed model. It also demonstrates the use of the 
model as an educational tool where the glycaemic ef-
fect of missing a morning injection is simulated for this 
patient. The hyperglycaemia which would result is pre-
dicted to reach a maximum of 16.8 mmol/l at 21:00 hrs.
A case study is presented to illustrate the potential of 
the model, e.g. comparing a non-diabetic subject ver-
sus an insulin-resistant subject.
CONCLUSIONS
This model, once coded in an easy to use simulator, 
intends to create an educational/learning experience for 
different users. However not all the functions catered for 
by the model will necessarily be of use to all users. Nev-
ertheless it is hoped that a user-friendly simulation pro-
gram incorporating this model would be a great help to 
in the periphery. The stomach and intestine are lumped 
into the gut compartment which serves as the location 
where exogenous glucose enters the body.
The diagram for insulin (right hand side, Figure 1) in-
cludes the plasma, liver, and periphery. The plasma com-
partment comprises the heart, lungs, kidneys and gut 
tissues where the hormone is removed. Endogenous se-
cretion delivers insulin directly to liver. Like in the glucose 
model, the periphery is divided into plasma and interstitial 
pools the latter being responsible for peripheral insulin 
action. Insulin is degraded at its primary action sites, the 
muscle and liver cells, and is also cleared by the kidneys. 
The pancreas is included as the site in which endogenous 
secretion takes place in people with NIDDM.
While glucose stimulates pancreatic insulin secre-
tion, insulin controls glucose production and utilisation 
in various organs and tissues. Muscle, along with the 
liver, is a site at which glucose uptake must be insulin-
mediated. Glucose regulates its own uptake through a 
mass action effect and through a regulatory mechanism 
that acts on the pathway enzymes. These interactions 
constitute the operating feedback loop that controls BG 
levels (middle panel of figure 1).
For glucose, these processes are glucose absorption 
following food ingestion, hepatic production and hepatic 
uptake, peripheral glucose uptake, kidney excretion and 
insulin-independent uptake in the brain and red blood 
cells. For insulin, rates are described for subcutaneous 
insulin absorption, pancreatic insulin release and for in-
sulin clearance by the liver, kidneys, and in the periphery. 
Linkage between glucose and insulin sub-models is es-
tablished by making hepatic glucose production and up-
take of glucose by the liver and peripheral compartments 
dependent on insulin concentration, and insulin release 
dependent on glucose concentration and its change. Us-
ing the diagram shown in Figure 1, it is possible to write 
mass balance equations for the two species in the vari-
ous body pools. These mass balance equations for each 
compartment and species (glucose and insulin) along 
with the specification of the relevant forcing functions 
constitute the mathematical model of glucose homeo-
stasis which can be used to predict how glucose/insulin 
concentrations evolve over time. a generic subcutaneous 
model of insulin analogue absorption has been incorpo-
rated into insulin analogue absorption model of Tarin et 
al. (17) Pancreatic insulin release appears as a source 
term in the liver insulin compartment. Simplified version 
of the Mari model has been incorporated. 
The overall model consists of 14 non-linear differential 
equations, 38 algebraic equations, and 58 parameters. 
The mass balance equations for the glucose and insu-
lin model are given subscripts distinguish physiological 
compartments. 
Readers are referred to Tarín et al. (17) for the details 
of the mathematical description of the model, and to Le-
hmann et al. (18-19) for information about the work that 
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780-793 – and – 2009; 3: 190-201. 
empower patients in their own diabetes self-manage-
ment. The educational model described allows users to 
simulate from a glycaemic perspective the 24-hour daily 
life of people with diabetes. It is proposed that an intui-
tive graphical user interface will allow users – even with-
out specific expertise in modelling – to interact with this 
glucose homeostasis model in an educational setting. 
Clearly it will also be important to extend the model to 
cover exercise and stress Compartmentalisation, param-
eterisation and modelling approaches were all chosen to 
allow for such extensions and revisions to be made more 
easily in later stages of the model’s development. 
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